Summary of CofixRX Testing – One Page Report

This is a one-pager resume -easy to print, read, and share- based on the report from the Institute for Antiviral Research at Utah State University presents the results from testing the virucidal effect of CoFixRx Nasal Spray against SARS-CoV-2 (Covid-19), Influenza B (the flu), HRV-14 (common cold), and RSV.